KADCYLA

Formula & Concentration

KADCYLA – ado-trastuzumab emtansine 100 and 160 mg intravenous solution

Manufacturer

Genentech Inc

Indications

HER2-positive carcinoma of breast

Product Options

Package Size

NDC #

Presentation

100 MG

50242-0088-01

POWDER

160 MG

50242-0087-01

POWDER

Shelf Life and Storage

Fridge (2-8°C)